Literature DB >> 12690204

Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics.

Simon Mead1, Michael P H Stumpf, Jerome Whitfield, Jonathan A Beck, Mark Poulter, Tracy Campbell, James B Uphill, David Goldstein, Michael Alpers, Elizabeth M C Fisher, John Collinge.   

Abstract

Kuru is an acquired prion disease largely restricted to the Fore linguistic group of the Papua New Guinea Highlands, which was transmitted during endocannibalistic feasts. Heterozygosity for a common polymorphism in the human prion protein gene (PRNP) confers relative resistance to prion diseases. Elderly survivors of the kuru epidemic, who had multiple exposures at mortuary feasts, are, in marked contrast to younger unexposed Fore, predominantly PRNP 129 heterozygotes. Kuru imposed strong balancing selection on the Fore, essentially eliminating PRNP 129 homozygotes. Worldwide PRNP haplotype diversity and coding allele frequencies suggest that strong balancing selection at this locus occurred during the evolution of modern humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12690204     DOI: 10.1126/science.1083320

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  116 in total

1.  Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway.

Authors:  Sofie Nyström; Rajesh Mishra; Simone Hornemann; Adriano Aguzzi; K Peter R Nilsson; Per Hammarström
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  Exploring amyloid formation by a de novo design.

Authors:  Richard A Kammerer; Dirk Kostrewa; Jesús Zurdo; Andreas Detken; Carlos García-Echeverría; Janelle D Green; Shirley A Müller; Beat H Meier; Fritz K Winkler; Christopher M Dobson; Michel O Steinmetz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-26       Impact factor: 11.205

3.  Modifier locus of the skeletal muscle involvement in Emery-Dreifuss muscular dystrophy.

Authors:  B Granger; L Gueneau; V Drouin-Garraud; V Pedergnana; F Gagnon; R Ben Yaou; S Tezenas du Montcel; G Bonne
Journal:  Hum Genet       Date:  2010-11-10       Impact factor: 4.132

4.  Analysis of single nucleotide polymorphisms of PRNP gene in twenty-four ethnic groups of India.

Authors:  Mainak Sengupta; Amrita Chakraborty; Kunal Ray
Journal:  J Genet       Date:  2010-08       Impact factor: 1.166

Review 5.  Prion amyloid structure explains templating: how proteins can be genes.

Authors:  Reed B Wickner; Frank Shewmaker; Herman Edskes; Dmitry Kryndushkin; Julie Nemecek; Ryan McGlinchey; David Bateman; Chia-Lin Winchester
Journal:  FEMS Yeast Res       Date:  2010-12       Impact factor: 2.796

6.  Molecular evolution of the sheep prion protein gene.

Authors:  Jon Slate
Journal:  Proc Biol Sci       Date:  2005-11-22       Impact factor: 5.349

7.  Genetic variability in a genomic region with long-range linkage disequilibrium reveals traces of a bottleneck in the history of the European population.

Authors:  Claudia Schmegner; Josef Hoegel; Walther Vogel; Günter Assum
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

8.  Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD.

Authors:  Manuela Pastore; Steven S Chin; Karen L Bell; Zhiqian Dong; Qiwei Yang; Lizhu Yang; Jue Yuan; Shu G Chen; Pierluigi Gambetti; Wen-Quan Zou
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

9.  Prion protein gene M129 allele is a risk factor for Alzheimer's disease.

Authors:  M Gacia; K Safranow; M Styczyńska; K Jakubowska; B Pepłońska; M Chodakowska-Zebrowska; I Przekop; A Słowik; E Golańska; K Hułas-Bigoszewska; D Chlubek; D Religa; C Zekanowski; M Barcikowska
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

10.  Progress and problems in the biology, diagnostics, and therapeutics of prion diseases.

Authors:  Adriano Aguzzi; Mathias Heikenwalder; Gino Miele
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.